Journal Article
|CommentaryFocusing on quality patient care in the new global subsidy for malaria medicines
Abstract
Tido von Schoen-Angerer and colleagues discuss the new Affordable Medicines Facility for malaria (AMFm), which subsidizes and facilitates access to artemisinin-based combination therapy, and what mechanisms are needed to ensure it stays focused on quality patient care.
Subject Area
Languages
English